| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042061173 |
| P356 | DOI | 10.1038/AJG.2009.646 |
| P932 | PMC publication ID | 3835753 |
| P698 | PubMed publication ID | 19920808 |
| P5875 | ResearchGate publication ID | 38096572 |
| P50 | author | C. Prakash Gyawali | Q87735783 |
| P2093 | author name string | Gregory S Sayuk | |
| Vladimir M Kushnir | |||
| P2860 | cites work | Wireless pH monitoring in patients with non-cardiac chest pain. | Q51246478 |
| Nonacid reflux in patients with chronic cough on acid-suppressive therapy. | Q51791648 | ||
| Chest pain and gastroesophageal reflux disease. | Q52118719 | ||
| Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. | Q52978330 | ||
| Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. | Q53387647 | ||
| Long-term follow-up of symptomatic status of patients with noncardiac chest pain: is diagnosis of esophageal etiology helpful? | Q55061068 | ||
| The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring | Q68281282 | ||
| Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease | Q81635329 | ||
| Long-term outcome from tricyclic antidepressant treatment of functional chest pain | Q33814182 | ||
| Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough | Q33880364 | ||
| Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics | Q34311576 | ||
| Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin | Q34392380 | ||
| ACG practice guidelines: esophageal reflux testing | Q34576807 | ||
| Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole | Q35598218 | ||
| Gastroesophageal reflux disease in noncardiac chest pain | Q35736044 | ||
| Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis | Q36163120 | ||
| Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease | Q36398688 | ||
| The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data | Q36726599 | ||
| The proton pump inhibitor (PPI) test in GERD: does it still have a role? | Q37223427 | ||
| Noncardiac chest pain-treatment approaches | Q37332994 | ||
| Esophageal-reflux monitoring | Q37403059 | ||
| Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication | Q41689686 | ||
| Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain | Q47315681 | ||
| Ambulatory esophageal pH monitoring using a wireless system | Q47924805 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1032-1038 | |
| P577 | publication date | 2009-11-17 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain | |
| P478 | volume | 105 |
| Q90322807 | A budget impact analysis of a magnetic sphincter augmentation device for the treatment of medication-refractory mechanical gastroesophageal reflux disease: a United States payer perspective |
| Q36589165 | Achalasia symptom response after Heller myotomy segregated by high-resolution manometry subtypes |
| Q39238495 | Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial |
| Q37648188 | Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring |
| Q42148170 | Bravo 48-hour Wireless pH Monitoring in Patients With Non-cardiac Chest Pain. Objective Gastroesophageal Reflux Disease Parameters Predict the Responses to Proton Pump Inhibitors |
| Q84475117 | Clinical outcomes of atypical extra-esophageal reflux symptoms following laparoscopic antireflux surgery |
| Q50088928 | Determinants of the Association between Non-Cardiac Chest Pain and Reflux |
| Q34481344 | Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis |
| Q34178751 | Esophageal hypersensitivity |
| Q48314221 | Esophageal mucosal mast cell infiltration and changes in segmental smooth muscle contraction in noncardiac chest pain |
| Q36589161 | Exaggerated smooth muscle contraction segments on esophageal high-resolution manometry: prevalence and clinical relevance |
| Q47915951 | Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. |
| Q36730840 | GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation. |
| Q35563400 | High resolution manometry patterns distinguish acid sensitivity in non-cardiac chest pain |
| Q90116077 | Magnetic sphincter augmentation: Optimal patient selection and referral care pathways |
| Q37989175 | Management of noncardiac chest pain in women |
| Q37880175 | Meta-analysis: the epidemiology of noncardiac chest pain in the community |
| Q50043480 | Modern diagnosis of GERD: the Lyon Consensus |
| Q34976198 | Noncardiac chest pain: epidemiology, natural course and pathogenesis |
| Q35118901 | Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease |
| Q37697569 | Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors |
| Q40961323 | Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring. |
| Q37330321 | The Effect of Antisecretory Therapy and Study Duration on Ambulatory Esophageal pH Monitoring |
Search more.